Contact your GP or prescribing clinician if you experience : Severe or worsening fatigue that significantly impairs daily activities or persists beyond several weeks of treatment Extreme weakness or inability to perform usual tasks Dizziness or fainting , particularly on standing, which may indicate dehydration or blood pressure changes Persistent nausea or vomiting preventing adequate food or fluid intake Signs of dehydration : dark urine, reduced urination, dry mouth, confusion Chest pain, palpitations, or breathlessness accompanying tiredness Mood changes , including low mood or depression, which can manifest as fatigue Right upper abdominal pain, fever or yellowing of the skin/eyes , which could indicate gallbladder problems (GLP-1 medications may increase gallstone risk) For urgent but non-emergency concerns, you can contact NHS 111 for advice
B12 injections deliver a high dose of vitamin B12 directly into your muscle, which helps your body absorb it quickly
Individuals with Wilson's disease or other copper metabolism disorders should avoid GHK-Cu supplementation
Our peptide therapy program stands out because we're transparent about what is and isn't FDA-approved
Polymorphism of glutathione S-transferase M3: interaction with glutathione [PMID: 23885907] Laboratory literature summary: Polymorphism of glutathione S-transferase M3: interaction with glutathione S-transferase M1 and lung oncology research models susceptibility